These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 19233645)
1. New prostaglandin derivative for glaucoma treatment. Perrino E; Uliva C; Lanzi C; Soldato PD; Masini E; Sparatore A Bioorg Med Chem Lett; 2009 Mar; 19(6):1639-42. PubMed ID: 19233645 [TBL] [Abstract][Full Text] [Related]
2. Discovery of 13-oxa prostaglandin analogs as antiglaucoma agents: synthesis and biological activity. Feng Z; Hellberg MR; Sharif NA; McLaughlin MA; Williams GW; Scott D; Wallace T Bioorg Med Chem; 2009 Jan; 17(2):576-84. PubMed ID: 19101156 [TBL] [Abstract][Full Text] [Related]
3. Prostaglandins as ocular hypotensive agents; development of an analogue for glaucoma treatment. Stjernschantz J Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():63-8. PubMed ID: 7732906 [No Abstract] [Full Text] [Related]
4. Studies on ocular inflammation and development of a prostaglandin analogue for glaucoma treatment. Stjernschantz J Exp Eye Res; 2004 Apr; 78(4):759-66. PubMed ID: 15037110 [TBL] [Abstract][Full Text] [Related]
6. Effect of topical 0.03% flurbiprofen and 0.005% latanoprost, alone and in combination, on normal canine eyes. Pirie CG; Maranda LS; Pizzirani S Vet Ophthalmol; 2011 Mar; 14(2):71-9. PubMed ID: 21366821 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of new hydrogen sulfide-releasing hybrids. Sparatore A; Santus G; Giustarini D; Rossi R; Del Soldato P Expert Rev Clin Pharmacol; 2011 Jan; 4(1):109-21. PubMed ID: 22115352 [TBL] [Abstract][Full Text] [Related]
9. Mechanism of the prostaglandin-induced reduction of intraocular pressure in humans. Camras CB Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():519-25. PubMed ID: 7732900 [No Abstract] [Full Text] [Related]
10. Efficacy and safety of bimatoprost as replacement for latanoprost in patients with glaucoma or ocular hypertension: a uniocular switch study. Casson RJ; Liu L; Graham SL; Morgan WH; Grigg JR; Galanopoulos A; Crawford A; House PH J Glaucoma; 2009; 18(8):582-8. PubMed ID: 19826386 [TBL] [Abstract][Full Text] [Related]
11. Prostaglandin analogues: a new classification of ocular hypotensive agents used in the treatment of glaucoma. Gallucci GM Nurse Pract; 1996 Nov; 21(11):144-6. PubMed ID: 8933541 [No Abstract] [Full Text] [Related]
12. Potential roles of (endo)cannabinoids in the treatment of glaucoma: from intraocular pressure control to neuroprotection. Nucci C; Bari M; Spanò A; Corasaniti M; Bagetta G; Maccarrone M; Morrone LA Prog Brain Res; 2008; 173():451-64. PubMed ID: 18929127 [TBL] [Abstract][Full Text] [Related]
13. New treatments for ocular hypertension. Mediero A; Alarma-Estrany P; Pintor J Auton Neurosci; 2009 May; 147(1-2):14-9. PubMed ID: 19176290 [TBL] [Abstract][Full Text] [Related]